Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort

A Mondi, A Cozzi‐Lepri, A Tavelli… - African Journal of …, 2019 - journals.lww.com
Introduction: Concerns about dolutegravir (DTG) tolerability in the real-life setting have
recently arisen. We aimed to estimate the risk of treatment discontinuation and virological
failure of DTG-based regimens from a large cohort of HIV-infected individuals. Methods: We
performed a multicentre, observational study including all antiretroviral therapy (ART)-naıve
and virologically suppressed treatment-experienced (TE) patients from the Icona (Italian
Cohort Naıve Antiretrovirals) cohort who started, for the first time, a DTG-based regimen from …
以上显示的是最相近的搜索结果。 查看全部搜索结果